This activity features presentations from three prominent physicians who participated in a double-blind, prospective, randomized, multicenter, parallel-group clinical trial in an at-risk patient population, to compare the renal tolerability of two leading contrast agents. The presentations will provide background information on the issues related to Contrast Induced Nephropathy (CIN) and best practices in how to best reduce the risk of CIN in patients with renal disease.

 

Hear from physicians who participated in the IMPACT Study and review their protocols for avoiding the possibility of CIN.

PART ONE:

CIN in Patients with Chronic Kidney Disease

Brendan Barret, MD

PART TWO:

Efficacy of Contrast Enhancement and Effect on the Heart Rate with Iopamidol 320 and Iodixanol

Dushyant Sahani, MD

PART THREE:

Optimizing Contrast Delivery - A Comparison of the Efficacy and Safety of Iopamidol-370 and Iodixanol-320 in Patients Undergoing MDCT

Jay Heiken, MD

This program is supported by an unrestricted grant from Bracco and Sponsored by ArcMesa Educators and Applied Radiology

 

 

Upon completion of this activity the participant will be able to:

 

1.   Understand the effects of contrast in patients with moderate-to-serve chronic kidney disease.

 

2.   Understand how to assess/identify patients who may be at risk of Contrast Induced Nephropathy (CIN)

 

3.   Understand the non-contrast protocols for patients determined to be at high risk of CIN.

 

4.   Understand the principles that govern the timing and magnitude of arterial and hepatic contrast enhancement.

 

5.   Understand the differences between MDCT scanners with regards to the timing of contrast enhancement and the protocols for your particular scanner.

 

 

 

Dr. Brendan Barrett, MD,

Memorial University of Newfoundland.

 

 

Dr. Brendan Barrett is a professor of medicine at Memorial University of Newfoundland, a staff nephrologist and clinical epidemiologist. He is responsible of for the overall co-ordination planning and evaluation of kidney care services in Newfoundland and Labrador.

 

Dushyant Sahani, MD,

Assistant Professor of Radiology at Harvard Medical School and Director of Computed Tomography at Massachusetts General Hospital, both in Boston, MA.

 

 

Dr. Sahani earned his medical degree and completed an internship at Panjabrao Deshmukh Memorial Medical College in Amravati, India. He completed his residency in radiology at Tata Memorial Hospital in Mumbai, India, and his fellowship in abdominal imaging and intervention at Massachusetts General Hospital and Harvard Medical School. Liver and pancreas imaging and oncological imaging have been a focus of his research and clinical work. He is currently involved in clinical trials to assess tumor angiogenesis and response of novel cancer treatment methods with CT and MRI. Dr. Sahani has contributed over 34 original papers to the medical literature, as well as various reviews and book chapters. He has conducted various lectures nationally and internationally and has provided medical education to residents, fellows, and HMS students. In addition, he has been a visiting professor at various universities in the United States and abroad. In 2005, he has earned a research award from the Society of Gastrointestinal Radiology and Cum-Laude from Society of Computed Body Tomography and MR. Dr. Sahani is the site study director for the clinical studies at MGH to be conducted in collaboration with CAD Sciences.

 

Jay Heiken, MD,

Professor of Radiology at the Mallinckrodt Institute of Radiology at Washington University School of Medicine, where he also is Director of Abdominal Imaging.

 

 

Dr. Heiken earned his bachelor's degree at Williams College in Williamstown, Massachusetts, where he graduated magna cum laude before receiving his medical degree from Columbia University College of Physicians and Surgeons in New York, New York. Dr. Heiken completed his internship in internal medicine at Emory University Affiliated Hospitals in Atlanta, Georgia, and his residency in radiology at Columbia-Presbyterian Medical Center in New York, New York. He completed a fellowship in abdominal radiology at the Mallinckrodt Institute of Radiology at Washington University School of Medicine in St. Louis, Missouri.

 

Dr. Heiken is a member of the Board of Directors of the Society of Gastrointestinal Radiologists (SGR) and the Board of Trustees of the International Cancer Imaging Society (ICIS). He is a past President of the Society of Computed Body Tomography and Magnetic Resonance (SCBT/MR) and has served as Chair of the Gastrointestinal Subcommittee of the Radiological Society of North America (RSNA) Scientific Program Committee. He also is a member of the Distinguished Roster of Scientific Advisors of the RSNA. He currently serves on 5 committees of the American College of Radiology including the Committee on Body Computed Tomography, the Commission on Research and Technology, the ACRIN Gastrointestinal Disease Site Committee, the Appropriateness Criteria Expert Panel on Gastrointestinal Imaging, and the Committee on Drugs and Contrast Media. He is an examiner for the American Board of Radiology and a member of the editorial board of Abdominal Imaging and the Korean Journal of Radiology.

 

Dr. Heiken has co-authored 100 peer-reviewed articles, 46 book chapters and invited publications, and has edited and co-authored 4 books. He has presented scientific papers at conferences across the United States, lectured as a visiting professor in more than 25 national and international universities, and has taught more than140 courses and symposia. Dr. Heiken has received the Cum Laude Award and the Hounsfield Award of the SCBT/MR for scientific papers. He has received the Resident's Distinguished Teaching Award from the Mallinckrodt Institute of Radiology and the Visiting Professor Award from the Society of Gastrointestinal Radiologists.

 

 

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of ArcMesa Educators and WebMedEd. ArcMesa Educators is accredited by the ACCME to provide continuing medical education for physicians.

 

This program is approved for up to 1 credit hour of Category 1 AMA/PRA Credit. The ARRT accepts Category 1 AMA/PRA credits as Category B credit.

---

---